Our finding of elevated levels of TNF-α, IL-2R, CD163, eotaxin, and HGF in VS-CM being significantly associated with hearing impairment in patients with VS suggests that inflammatory pathways and immune cell activation are key contributors to VS-induced hearing loss. This evidence concerns the gene CD163 and hearing loss disorder.